CVE-2026-21974
- State
- Published
- Severity
- 5.3 Medium
- Published
- Jan 20, 2026
- Updated
- Jan 21, 2026
- Reserved
- Jan 5, 2026
Description
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).
Scores
| CVSS | Score | Vector | Source |
|---|---|---|---|
| 3.1 | 5.3 Medium | CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N | oracle |
Weaknesses
- CWE-200 Exposure of Sensitive Information to an Unauthorized Actor
Affected Products
| Product | Versions |
|---|---|
Oracle Life Sciences Central DesignerOracle Corporation |
|
References
- Oracle Advisoryvendor-advisory
Every record here comes from the CVE Program’s CVE List. © 1999–2026 The MITRE Corporation. CVE is a registered trademark of The MITRE Corporation. The records are reproduced under the CVE Program terms of use.